Table of Contents:
Cannabinols have some mild intoxicating actions and are found at higher levels in aged cannabis. The cannabinols appear to be degradation products of THC and THCA. The CBNs as a group have been tested in various animal models. CBNs appear to exhibit some toxicity and mutagenicity. When zebrafish embryos are exposed to these materials, an increase the frequency of anatomic anomalies was noted. 
In a rat model for facial pain, different combinations of CBD and CBN had different effects. Overall, the combination of CBD and CBN appeared to be useful in reducing pain in this animal model. 
Other studies have found antibacterial  effects in lab or animal studies. One study determined that cannabinol may have anti-growth and anti-proliferation effects in tumor cell lines derived from brain, liver and breast cancer cells.  No human studies have been done, but CBNs may be useful in preventing or treating Alzheimer’s disease and other neurodegenerative disorders because of its neuroprotection effects. CBNs also demonstrate anti-glaucoma properties  and, –along with CBDL, has anti-inflammatory effects. 
Not very much is known about the cannabinodiols, but they are mildly psychoactive and are derived from the CBNs. There is some data indicating they exhibit anti-inflammatory effects  as well as anti-anxiety effects. 
The cannabinols and the cannabinodiols include the following:
There has not yet been enough work done to determine the potential benefits of these primarily non-intoxicating cannabinoids. Based on the work done so far, it is reasonable to think that these substances may be useful as:
These are substances that are found in hemp and other cannabis plants at very very low levels. The law is way behind the science, and as long as a product contains less than 0.3% THC, technically, the law doesn’t seem to care about other cannabinoids.
To date, we could not find any of these products for sale by any company. However, there are a number of strains of hemp and cannabis that produce higher levels of these cannabinoids, so it would not be too surprising if there were some products offered relatively soon.
You will have to stay tuned for new research on these cannabinoids! Not much has been done beyond determining the structures and some of the physical properties of these unique molecules. There are also more cannabinoids waiting to be characterized. In addition to the cannabinoids mentioned, there are whole classes of compounds including cannabitriols, cannabielsoins, cannabicyclols and “miscellaneous” cannabinoids waiting in the wings. Some of these may have no particular use for humans while others may prove valuable. One thing is certain, however, these are unique structures and nearly all are unique to the Cannabis plant. Other plants like the coneflower (echinacea), the everlasting flower (helichrysum), liverwort (radula), kava (piper methysticum) and others synthesize substances that are known as cannabinomimetics.—These substances act in some ways like cannabinoids, but are structurally different.  Cannabinomimetic substances bind to the CB1 and CB2 receptors along with other receptors. Who knows what we will eventually learn about these substances!